Related Experiment Videos
Interferon alfa for macular degeneration
1Womack Army Medical Center, Ft Bragg, NC 28307, USA.
The Annals of Pharmacotherapy
|June 1, 1996
Abstract:
Clinical studies demonstrate that interferon alfa has little benefit in treating CNV secondary to macular degeneration. However, it may be useful in the treatment of choroidal and retinal hemangiomas, diabetic and post-vein occlusion retinopathy, and retinopathy of prematurity.